Response to everolimus in a patient with refractory HGBL-NOS harboring multiple genomic aberrations in PTEN
Imogen Caldwell, David Byrne, Stephen Lade, Tim Akhurst, Adrian Minson, Michael Dickinson, Ella Thompson, Clare Scott, Piers Blombery
LEUKEMIA & LYMPHOMA | TAYLOR & FRANCIS LTD | Published : 2021
The authors would like to acknowledge funding from the Stafford Fox Medical Research Foundation, the Snowdome Foundation and the Wilson Centre for lymphoma genomics. IC is a recipient of the Mike and Carole Ralston Traveling Fellowship (2020) from the RCPA Foundation.